Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Additional supporting files.zip
0
Zitationen
8
Autoren
2022
Jahr
Abstract
Our research aims to identify CRT as a potential drug candidate for MN, and revealed that the treatment of CRT may effectively ameliorate renal dysfunction and reduce the podocyte injury via targeting the TNF-α-IL-6-JAK2/STAT3-MMP9 signaling axis, which may facilitate its clinical application in MN therapy. This dataset stores all the original data in this study.
Ähnliche Arbeiten
A New Equation to Estimate Glomerular Filtration Rate
2009 · 25.214 Zit.
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 · 7.040 Zit.
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate
2006 · 5.716 Zit.
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 · 4.767 Zit.
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 · 4.379 Zit.